INBX – inhibrx, inc. (US:NASDAQ)
Stock Stats
News
Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap [Seeking Alpha]
Inhibrx Biosciences (NASDAQ:INBX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
Inhibrx Biosciences GAAP EPS of -$2.28 [Seeking Alpha]
Inhibrx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Inhibrx Reports Third Quarter 2025 Financial Results
Form 10-Q Inhibrx Biosciences, For: Sep 30
Form 8-K Inhibrx Biosciences, For: Nov 14
Form 8-K Inhibrx Biosciences, For: Oct 23
Form SCHEDULE 13G/A Inhibrx Biosciences, Filed by: BlackRock, Inc.
Form 4 Inhibrx Biosciences, For: Oct 07 Filed by: Shabet Rose Sharon
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.